CCM Valuation

Concord Medical Services Holdings Ltd

Add to Watchlist

Advanced Chart

5.315

+0.125(2.408%)1D

Overview
Forecast
Valuation
Earnings

CCM Relative Valuation

CCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CCM is overvalued; if below, it's undervalued.

Historical Valuation

Concord Medical Services Holdings Ltd (CCM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.48 is considered Undervalued compared with the five-year average of -34.03. The fair price of Concord Medical Services Holdings Ltd (CCM) is between 8.45 to 28.87 according to relative valuation methord. Compared to the current price of 5.32 USD , Concord Medical Services Holdings Ltd is Undervalued By 37.07%.

Relative Value

Fair Zone

8.45-28.87

Current Price：5.32

37.07%

Undervalued

-18.54

Trailing

Forward

65.65

EV/EBITDA

Concord Medical Services Holdings Ltd. (CCM) has a current EV/EBITDA of 65.65. The 5-year average EV/EBITDA is 16.15. The thresholds are as follows: Strongly Undervalued below -148.16, Undervalued between -148.16 and -66.01, Fairly Valued between 98.31 and -66.01, Overvalued between 98.31 and 180.47, and Strongly Overvalued above 180.47. The current Forward EV/EBITDA of 65.65 falls within the Historic Trend Line -Fairly Valued range.

-555.91

EV/EBIT

Concord Medical Services Holdings Ltd. (CCM) has a current EV/EBIT of -555.91. The 5-year average EV/EBIT is -410.47. The thresholds are as follows: Strongly Undervalued below -886.31, Undervalued between -886.31 and -648.39, Fairly Valued between -172.55 and -648.39, Overvalued between -172.55 and 65.37, and Strongly Overvalued above 65.37. The current Forward EV/EBIT of -555.91 falls within the Historic Trend Line -Fairly Valued range.

0.48

Concord Medical Services Holdings Ltd. (CCM) has a current PS of 0.48. The 5-year average PS is 1.67. The thresholds are as follows: Strongly Undervalued below -0.63, Undervalued between -0.63 and 0.52, Fairly Valued between 2.82 and 0.52, Overvalued between 2.82 and 3.97, and Strongly Overvalued above 3.97. The current Forward PS of 0.48 falls within the Undervalued range.

0.00

P/OCF

Concord Medical Services Holdings Ltd. (CCM) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Concord Medical Services Holdings Ltd. (CCM) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Concord Medical Services Holdings Ltd (CCM) has a current Price-to-Book (P/B) ratio of -0.07. Compared to its 3-year average P/B ratio of -0.15 , the current P/B ratio is approximately -53.42% higher. Relative to its 5-year average P/B ratio of -0.43, the current P/B ratio is about -83.39% higher. Concord Medical Services Holdings Ltd (CCM) has a Forward Free Cash Flow (FCF) yield of approximately -493.37%. Compared to its 3-year average FCF yield of -114.99%, the current FCF yield is approximately 329.07% lower. Relative to its 5-year average FCF yield of -81.83% , the current FCF yield is about 502.92% lower.

-0.07

P/B

Median3y

-0.15

Median5y

-0.43

-493.37

FCF Yield

Median3y

-114.99

Median5y

-81.83

Competitors Valuation Multiple

The average P/S ratio for CCM's competitors is 1.49, providing a benchmark for relative valuation. Concord Medical Services Holdings Ltd Corp (CCM) exhibits a P/S ratio of 0.48, which is -67.79% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

CCM.N

Concord Medical Services Holdings Ltd

Dyadic International Inc

Intelligent Bio Solutions Inc

Basel Medical Group Ltd

Loss

39.26M

Performance Decomposition

Market capitalization of CCM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of CCM in the past 1 year is driven by Unknown.